| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 208,780 | 178,785 | 199,727 | | Cost of Revenue | 182,050 | 167,280 | 185,111 | | | Gross Profit | 26,730 | 11,505 | 14,616 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 6,028 | 4,831 | 5,153 | | Non Recurring |
-
|
-
| (1,313) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 20,701 | 6,674 | 10,776 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 145 | 201 | 132 | | Earnings Before Interest And Taxes | 20,846 | 6,876 | 10,908 | | Interest Expense | 23 | 90 | 29 | | Income Before Tax | 20,823 | 6,786 | 10,879 | | Income Tax Expense | 7,149 | 2,321 | 3,860 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,673 | 4,465 | 7,018 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 13,673 | 4,465 | 7,018 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,673 | $4,465 | $7,018 |
|
1.00% Nasdaq 
Income Statement
